Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry.
Explore this paper's citation graph
Summary
The data show use of DES over BMS provided advantages to patients with acute coronary syndrome in terms of lower 1-year mortality, TVR, and MACE, and suggests implantation of DES compared with BMS in Taiwanese patients with ACS is safe and beneficial in the real-world setting.
- Type
- article
- Published
- 2014-11-01
- Cited by
- 11
- References
- 41
- OpenAlex
- https://openalex.org/W27122834
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:36524868
Keywords
Geography
References
- Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
- 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Ele
- Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.
- Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.
- Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
- EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION
- 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
- Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.
- The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.
- Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction.
- Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.
- Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
- Comparison of the impact of short ( or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.
- Guidelines on myocardial revascularization.
- Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
- Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction: Eight-Month Follow-Up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) Trial
- Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).
- Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI).
- Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study).
Cited by
- One‐year cardiovascular outcomes of drug‐eluting stent versus bare‐metal stent implanted in diabetic patients with acute coronary syndrome
- Author Reply to Letter to the Editor: Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry.
- Renal Function Should be Considered in Determining Superiority of Drug-Eluting Stents over Bare-Metal Stents in Patients with Acute Coronary Syndrome.
- Baseline Hemoglobin Levels Associated with One-Year Mortality in ST-Segment Elevation Myocardial Infarction Patients.
- Retrograde Approach is as Effective and Safe as Antegrade Approach in Contemporary Percutaneous Coronary Intervention for Chronic Total Occlusion: A Taiwan Single-Center Registry Study.
- The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care.
- Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience.
- Clinical Impact of High-Sensitivity Cardiac Troponin T on the Chronic Phase of Stable Angina after a Successful Initial Percutaneous Coronary Intervention.
- Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
- Percutaneous Coronary Intervention Clinical Impact of High-Sensitivity Cardiac Troponin T on the Chronic Phase of Stable Angina after a Successful Initial Percutaneous Coronary Intervention
- Impact of different dose and duration of clopidogrel on the postoperative efficacy of drug-eluting stent implantation in patients with coronary heart disease and diabetic mellitus
Related papers
No related papers recorded.